Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram W Sabnis

Showing results (11-20 of 251) with videos related to

Pageof 26
Sort By:
ACS Medicinal Chemistry Letters|August 14, 2024
Novel KRAS Inhibitors for Treating Non-small Cell Lung CancerRam W Sabnis
ACS Medicinal Chemistry Letters|August 14, 2024
Novel Imidazopyridine and Imidazopyridazine Derivatives as DGAT2 Inhibitors for Treating Multiple DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|June 19, 2024
Imidazopyridine Compounds as ERK5 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|November 17, 2023
Protease Inhibitors for Treating or Preventing Coronavirus InfectionRam W Sabnis
ACS Medicinal Chemistry Letters|November 17, 2023
Novel Plasma Kallikrein Inhibitors for Treating Hereditary Angioedema, Diabetic Macular Edema, and Diabetic RetinopathyRam W Sabnis
ACS Medicinal Chemistry Letters|December 20, 2023
Novel PARP1 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|December 20, 2023
Novel Adenosine Receptor Antagonists for Treating Cancer and Immune-Related DisordersRam W Sabnis
ACS Medicinal Chemistry Letters|July 17, 2024
Novel Heterocyclic Compounds as Monoacylglycerol Lipase Inhibitors for Treating Multiple DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|July 17, 2024
Novel AHR Agonists for Treating Psoriasis and Atopic DermatitisRam W Sabnis
ACS Medicinal Chemistry Letters|June 19, 2024
Novel Furopyridine and Furopyrimidine Compounds as PI4K Inhibitors for Treating Malaria and Viral InfectionRam W Sabnis
Pageof 26

Showing results (11-20 of 251) with videos related to

Sort By:
Pageof 26
ACS Medicinal Chemistry Letters|August 14, 2024
Novel KRAS Inhibitors for Treating Non-small Cell Lung CancerRam W Sabnis
ACS Medicinal Chemistry Letters|August 14, 2024
Novel Imidazopyridine and Imidazopyridazine Derivatives as DGAT2 Inhibitors for Treating Multiple DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|June 19, 2024
Imidazopyridine Compounds as ERK5 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|November 17, 2023
Protease Inhibitors for Treating or Preventing Coronavirus InfectionRam W Sabnis
ACS Medicinal Chemistry Letters|November 17, 2023
Novel Plasma Kallikrein Inhibitors for Treating Hereditary Angioedema, Diabetic Macular Edema, and Diabetic RetinopathyRam W Sabnis
ACS Medicinal Chemistry Letters|December 20, 2023
Novel PARP1 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|December 20, 2023
Novel Adenosine Receptor Antagonists for Treating Cancer and Immune-Related DisordersRam W Sabnis
ACS Medicinal Chemistry Letters|July 17, 2024
Novel Heterocyclic Compounds as Monoacylglycerol Lipase Inhibitors for Treating Multiple DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|July 17, 2024
Novel AHR Agonists for Treating Psoriasis and Atopic DermatitisRam W Sabnis
ACS Medicinal Chemistry Letters|June 19, 2024
Novel Furopyridine and Furopyrimidine Compounds as PI4K Inhibitors for Treating Malaria and Viral InfectionRam W Sabnis
Pageof 26